ENvue Medical, Inc. (FEED)

Market Cap	5.05M +56.3%
Revenue (ttm)	2.18M -18.1%
Net Income	-37.52M
EPS	-26.15
Shares Out	6.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	460,704
Open	0.8580
Previous Close	0.8799
Day's Range	0.8132 - 0.8900
52-Week Range	0.7205 - 17.4000
Beta	1.50
Analysts	n/a
Price Target	22,000.00 (+2,653,059.67%)
Earnings Date	May 18, 2026

About FEED

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at-home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based thera...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: FEED
• Website: https://envuemed.com

Financial Performance

In 2025, ENvue Medical's revenue was $2.55 million, a decrease of -0.20% compared to the previous year's $2.56 million. Losses were -$16.78 million, 352.8% more than in 2024.